Teligent, Inc. – NASDAQ:TLGT
Teligent stock price today
Teligent stock price monthly change
Teligent stock price quarterly change
Teligent stock price yearly change
Teligent key metrics
Market Cap | N/A |
Enterprise value | 110.56M |
P/E | -0.04 |
EV/Sales | 2.38 |
EV/EBITDA | 66.79 |
Price/Sales | 0.35 |
Price/Book | -0.27 |
PEG ratio | N/A |
EPS | -0.18 |
Revenue | 46.29M |
EBITDA | 1.65M |
Income | -11.18M |
Revenue Q/Q | -23.20% |
Revenue Y/Y | -16.53% |
Profit margin | -24.15% |
Oper. margin | -61.29% |
Gross margin | -60.01% |
EBIT margin | -61.29% |
EBITDA margin | 3.58% |
create your own Smart Feed
Personalize your watchlist with companies you want to keep track of and get notified in the smart feed every time fresh news arrives.
Sign up for freeTeligent stock price history
Teligent stock forecast
Teligent financial statements
| Sep 2020 | 14.33M | -510K | -3.56% |
|---|---|---|---|
| Dec 2020 | 9.93M | 41.16K | 0.41% |
| Mar 2021 | 11.58M | 2.15M | 18.58% |
| Jun 2021 | 10.43M | -12.86M | -123.32% |
| 2020-08-19 | -1.7 | -1.54 |
|---|---|---|
| 2020-12-31 | -1.48 | -2.09 |
| 2021-05-25 | -1.96 | 0.03 |
| Sep 2020 | 190253000 | 230.34M | 121.07% |
|---|---|---|---|
| Dec 2020 | 83887000 | 197.94M | 235.96% |
| Mar 2021 | 100778000 | 148.47M | 147.33% |
| Jun 2021 | 90419000 | 149.30M | 165.13% |
| Sep 2020 | -4.46M | -795K | 9.22M |
|---|---|---|---|
| Dec 2020 | -1.16M | -731K | -3.64M |
| Mar 2021 | -10.87M | -47K | 32.41M |
| Jun 2021 | -6.54M | -182K | 1.97M |
Teligent alternative data
| Aug 2023 | 142 |
|---|---|
| Sep 2023 | 142 |
| Oct 2023 | 142 |
| Nov 2023 | 142 |
| Dec 2023 | 142 |
| Jan 2024 | 142 |
| Feb 2024 | 142 |
| Mar 2024 | 142 |
| Apr 2024 | 142 |
| May 2024 | 142 |
| Jun 2024 | 142 |
| Jul 2024 | 142 |
Teligent other data
| Period | Buy | Sel |
|---|---|---|
| Aug 2020 | 0 | 1738566 |
| May 2021 | 30000 | 0 |
| Quarter | Transcript |
|---|---|
| Q2 2021 16 Aug 2021 | Q2 2021 Earnings Call Transcript |
| Q2 2020 19 Aug 2020 | Q2 2020 Earnings Call Transcript |
| Q1 2020 22 May 2020 | Q1 2020 Earnings Call Transcript |
| Q4 2019 8 Apr 2020 | Q4 2019 Earnings Call Transcript |
Friday, 15 October 2021 | ||
| TLGT Stock: Why The Price Substantially Fell | Pulse2 | |
Sunday, 19 September 2021 | ||
| Top Penny Stocks to Buy Right Now? 3 to Check Out This Month | PennyStocks | |
Monday, 16 August 2021 | ||
| Teligent, Inc. (TLGT) CEO Tim Sawyer on Q2 2021 Results - Earnings Call Transcript | Seeking Alpha | |
| Teligent, Inc. Announces Second Quarter 2021 Earnings Report and Provides Business Update | GlobeNewsWire |
-
What's the price of Teligent stock today?
One share of Teligent stock can currently be purchased for approximately $0.17.
-
When is Teligent's next earnings date?
Unfortunately, Teligent's (TLGT) next earnings date is currently unknown.
-
Does Teligent pay dividends?
No, Teligent does not pay dividends.
-
What is Teligent's stock symbol?
Teligent, Inc. is traded on the NASDAQ under the ticker symbol "TLGT".
-
What is Teligent's primary industry?
Company operates in the Healthcare sector and Drug Manufacturers - Specialty & Generic industry.
-
How do i buy shares of Teligent?
Shares of Teligent can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include WeBull, Vanguard Brokerage Services, TD Ameritrade, E*TRADE, Robinhood, Fidelity, and Charles Schwab.
-
How many employees does Teligent have?
As Jul 2024, Teligent employs 142 workers.
-
When Teligent went public?
Teligent, Inc. is publicly traded company for more then 44 years since IPO on 30 Jul 1981.
-
What is Teligent's official website?
The official website for Teligent is teligent.com.
-
Where are Teligent's headquarters?
Teligent is headquartered at 105 Lincoln Avenue, Buena, NEW JERSEY.
-
How can i contact Teligent?
Teligent's mailing address is 105 Lincoln Avenue, Buena, NEW JERSEY and company can be reached via phone at +1 609 697 1441.
Teligent company profile:
Teligent, Inc.
teligent.comNASDAQ
142
Drug Manufacturers - Specialty & Generic
Healthcare
Teligent, Inc., formerly Igi Laboratories Inc, is a specialty generic pharmaceutical company. Under the Company's own label, it markets and sells generic injectable pharmaceutical products in the United States and Canada. In the United States it marketed 35 generic topical pharmaceutical products and four branded generic pharmaceutical products, as of December 31, 2018. It provides development, formulation and manufacturing services to the pharmaceutical, over-the-counter (OTC) and cosmetic industries. It focuses on developing, manufacturing and marketing a portfolio of generic pharmaceutical products under its own label in topical, injectable, complex and ophthalmic dosage forms, and managing its contract manufacturing and formulation services business. Its pipeline included 20 Abbreviated New Drug Application (ANDAs) filed with the United States Food and Drug Administration (FDA) for additional pharmaceutical products, as of December 31, 2018.
Buena, NEW JERSEY 08310
CIK: 0000352998
ISIN: US87960W2035
CUSIP: 87960W203
